“Cancer Doctors Join Insurers in U.S. Revolt against Drug Costs” - Dr. Andrea D. Branch
The backlash over surging drug prices is starting to take hold. With the average cost of branded cancer drugs doubling over the past decade to about $10,000 per month in the U.S., doctors, insurers and politicians are all moving in different ways to pressure drug makers on pricing. Eradicating hepatitis C in everyone with the virus could make Sovaldi one of the biggest selling drugs in history. In the U.S. alone, the approximate cost to cure everyone may be $400 billion for Sovaldi and various companion drugs, assuming some patients need to be retreated, according to estimates from Andrea D. Branch, PhD, Professor of Medicine (Liver Diseases), and Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai. Learn more